Foundational Research
The Cicero Institute develops and advocates for bold state-level policies in challenging issue areas to restore liberty through accountability and transparency in American governance.
Restoring Competition to the Infant Formula Market
Executive SummaryMany parents rely on infant formula to feed their babies. Yet, in the United States, infant formula is expensive, the supply chain is vulnerable, and parents have limited options. The current infant formula market […]
9
Results
Filter by:
- Devon Kurtz (9)
- Dr. Chris Sharp (6)
- McKenzie Richards (6)
- Josh Archambault (6)
- Dr. Elinore McCance-Katz (5)
- Tanner H. Jones (5)
- Tim Frost (5)
- Jonathan Wolfson (4)
- Ryan Prenosil (4)
- Joshua Reynolds (3)
- Vittorio Nastasi (3)
- Ryan Quandt, Ph.D. (3)
- Christopher Jones (2)
- Michael Brickman (2)
- Adam Meier (2)
- Eve Velasquez (2)
- Paul Webster (2)
- Caleb Jacobs (2)
- Isabella Romboldi (2)
- Elena Gonzalez (1)
- Ariana Duduna (1)
- Erin Davis Valdez (1)
- Josie Pearce (1)
- Kristi Putnam (1)
- Jennifer Dirmeyer (1)
- Joey Torsella (1)
- Brian Blase (1)
- Ateev Mehrotra (1)
- Ally Perkins (1)
- Eli Oaks (1)
- Jack Brustkern (1)
- Matthew Nolan (1)
- (1)
- Jakob Dupuis (1)
- Integrating Treatment for Vulnerable Populations (11)
- Telehealth Across State Lines (6)
- Promoting Accountability and Outcomes (4)
- Protecting Public Spaces (4)
- Regulatory Sunset (4)
- Independent Regulatory Review (3)
- Regulatory Technology and Transparency (3)
- Eliminate Certificate of Need (3)
- Regulatory Review (3)
- Limiting Regulatory Authority (2)
- Pharmacist Patient Care (2)
- Regulatory Cost-Benefit Analysis (2)
- Merit-Based Staffing and Accountability (1)
- Infant Formula Competition (1)
- Artificial Intelligence (1)
- Higher Education Performance Funding (1)
- Reference-Based Pricing for State Employee Healthcare (1)
- Classroom Funding Transparency (1)
- Independent Office of Regulatory Review (1)
- Limiting Regulatory Authority with Delegation (1)
- Expanding Private Prison Competition (1)
- Removing the Red Tape on Regulatory Waivers (1)







